Kowieski Mark
SEC insider (Form 3/4/5 filer). CIK 0002024869. Chief Financial Officer at Evoke Pharma Inc (EVOK). 5 reported Form 4/5 transactions since Sep 2024; latest on Dec 17, 2025. Located in SOLANA BEACH, CA.
Companies Kowieski Mark has filed insider reports for
- Evoke Pharma Inc (EVOK): Officer, Chief Financial Officer
Kowieski Mark
CIK: 0002024869
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)3 (60.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EVOK
Evoke Pharma Inc
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Dec 17, 2025EVOK
Evoke Pharma Inc
DispositionDirectStock Option (Right to Buy)
17.3K shares- - Dec 17, 2025EVOK
Evoke Pharma Inc
DispositionDirectStock Option (Right to Buy)
13K shares- - Dec 16, 2025EVOK
Evoke Pharma Inc
Tender OfferDirect11.8K shares- - Mar 20, 2025EVOK
Evoke Pharma Inc
AwardDirect4.5K shares at avg. $3.21$14K - Jan 28, 2025EVOK
Evoke Pharma Inc
AwardDirectStock Option (Right to Buy)
13K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 17, 2025 | EVOK Evoke Pharma Inc | Disposition Stock Option (Right to Buy) | 17,291 | - | - | Direct |
| Dec 17, 2025 | EVOK Evoke Pharma Inc | Disposition Stock Option (Right to Buy) | 13,000 | - | - | Direct |
| Dec 16, 2025 | EVOK Evoke Pharma Inc | Tender Offer | 11,815 | - | - | Direct |
| Mar 20, 2025 | EVOK Evoke Pharma Inc | Award | 4,500 | $3.21 | $14,463 | Direct |
| Jan 28, 2025 | EVOK Evoke Pharma Inc | Award Stock Option (Right to Buy) | 13,000 | - | - | Direct |
1-5 of 5 transactions